Ginger and psoriatic arthritis and spondylitis: IL-17, IL-23, TNF-α, and enthesitis—immuno-inflammatory mechanisms

⚡ Direct Answer: A ginger shot without sugar inhibits the IL-23/IL-17 axis (central pathway of psoriatic arthritis and ankylosing spondylitis), reduces enthesitis via inflammation-mecanisme-cle-ginger-sucre-explication-2026">NF-κB in enthesocytes, inhibits TNF-α and RANKL-mediated bone erosion, and activates Nrf2 for enthesis chondrocyte protection. The sugar in INTI vs GIMBER comparison (~35g/100ml) enhances the Th17 axis via NF-κB → counterproductive in spondyloarthropathies.

Spondyloarthropathies: Beyond Classical RA

Spondyloarthropathies (SpA) are a group of inflammatory joint diseases distinct from RA:

  • Psoriatic Arthritis (PsA): ~2% of the population, associated with ginger psoriasis, affects peripheral joints, entheses, and nails.
  • Ankylosing Spondylitis (AS): axial inflammation (sacroiliac, spine), predominant enthesitis.

Central mechanism: IL-23/IL-17 axis — IL-23 differentiates Th17 → IL-17A → inflammatory cascade in joints, entheses, and bone. IL-17 is the primary therapeutic target (secukinumab, ixekizumab).

Ginger Mechanisms in SpA

Target Role in SpA Ginger Effect
IL-23 (macrophages) Th17 differentiation ↑ NF-κB ↓ macrophages → IL-23 ↓
IL-17A/F (Th17) Enthesis/bone/skin inflammation STAT3 ↓, RORγt ↓ → IL-17 ↓
NF-κB enthesocytes Enthesitis → mechanical pain NF-κB ↓ → IL-6, MMP-3 ↓
RANKL bone Bone erosion RANKL ↓ → osteoclasts ↓
TNF-α SpA cascade amplification TNF-α ↓ via NF-κB
NF-κB keratinocytes Cutaneous psoriasis Reduced ginger skin comorbidity

IL-23/IL-17 Axis Inhibition (Core of SpA)

Ginger inhibits IL-17 by reducing STAT3 (transcription factor essential for Th17 differentiation by IL-23) and RORγt (master transcription factor of Th17), and by directly reducing IL-17A, IL-17F expression in activated Th17 cells. Furthermore, ginger inhibits NF-κB in macrophages → ↓ IL-23 production → less Th17 differentiation upstream.

Enthesitis Reduction

The enthesis (tendon-bone junction) is the primary pathogenic site of SpA. IL-17 and TNF-α induce NF-κB in enthesocytes → overproduction of local cytokines and metalloproteases. Ginger inhibits NF-κB in enthesocytes → ↓ local IL-6, MMP-3 → less enthesitis → ↓ mechanical pain at entheses.

Bone Protection: RANKL and Erosions

In PsA and AS, IL-17 and TNF-α stimulate RANKL in enthesocytes and osteoblasts → osteoclasts → periarticular bone erosions. Ginger inhibits NF-κB → ↓ RANKL → ↓ entheseal osteoclasts → less bone erosions.

GIMBER and SpA: The Th17 Enhancer

  • Sugar → systemic NF-κB → macrophages → IL-23 ↑ → Th17 ↑ → IL-17 ↑ → SpA exacerbated
  • Fructose → AGE → RAGE → NF-κB → enhanced entheseal inflammation
  • Obesity (AMPK ↓) → adipokines (leptin) → pro-inflammatory Th17
❓ FAQ — Ginger and Spondyloarthropathies

Q: Does ginger replace anti-IL-17 biologics (secukinumab) for PsA/AS?
A: No. Secukinumab is the reference biological treatment for moderate to severe SpA. Ginger shares the IL-17 ↓ mechanism but with much lower potency. It can complement treatment but never replace it. Consult a rheumatologist.

Q: Does sugar worsen psoriatic arthritis?
A: Yes — obesity (correlated with sugar consumption) is a risk factor for PsA and exacerbates activity. TNF-α and IL-17 are higher in obese PsA patients.

🌿 Conclusion: Ginger inhibits the IL-23/IL-17 axis of SpA, reduces enthesitis, bone erosions, and cutaneous psoriasis. For these benefits without enhancing the Th17 axis with sugar, choose INTI — artisanal preparation organic ginger, 1.19g/100ml. The anti-inflammatory-science-utilisation">ginger anti-inflammatory drink for spondyloarthropathies.

Related articles

Read more about related topics:

Back to blog